Physician profile
Amanda Chelednik
NPI 1710337746
$16,811.50
in general payments reported to CMS, 2019-2025
11 companies · $1,310 in 2025
The $1,310 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $44.96 · 2021: $78.10 · 2022: $128 · 2023: $2,685 · 2024: $12K · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Travel and Lodging: $3,040 · Food and Beverage: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Travel and Lodging | $3,039.74 |
| Food and Beverage | $1,283.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,352.17 | 2023-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $611.91 | 2023 | Matrixrib |
| Ethicon US, LLC | $198.84 | 2019-2020 | |
| Integra Lifesciences Corporation | $184.35 | 2021-2022 | |
| Haemonetics Corporation | $153.48 | 2025 | Teg6s Hemostasis System |
| Depuy Synthes Sales INC. | $118.82 | 2023 | Matrixrib, Xcm Biologic Tissue Matrix |
| Edwards Lifesciences Corporation | $66.98 | 2019 | |
| Davol INC. | $63.30 | 2023 | |
| Solventum Corporation | $23.18 | 2025 | V.A.C.Instill |
| Polynovo North America LLC | $21.60 | 2021 | |
| Covidien LP | $16.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Chelednik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.